NXTM Financial Facts
General and administrative: 7.82MResearch and development: 5.11M
See Full Income Statement
Accounts payable: 20.59M
Total liabilities: 115.43M
See Full Balance Sheet
Earnings History for Nxstage Medical, Inc. (NXTM)
|
Expand Research on NXTM
| Next EPS Date | 8/7/13 *Est. | EPS Growth Rate | +11.1% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +35.8% | Revenue Growth Rate | +8.1% *Last Qtr. |
| Average % Move 1-Wk after EPS | +1.7% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
2/28/13  |
 |
Q412 | $0.00 | -$0.05 | +$0.05 | N/A | $63.54M | N/A / N/A | = | +25.3% | Details |
| 5/2/13 |
|
Q113 | -$0.08 | -$0.08 | $0.00 | $61.6M | $61.14M | N/A / N/A | = | +27.3% | Details |
| 11/8/12 |
|
Q312 | -$0.04 | -$0.06 | +$0.02 | $61.2M | $60.81M | N/A / N/A | = | +28.2% | Details |
| 8/8/12 |
|
Q212 | -$0.09 | -$0.10 | +$0.01 | $59M | $58.22M | N/A / N/A | = | -14.2% | Details |
| 5/8/12 |
|
Q112 | -$0.09 | -$0.10 | +$0.01 | $57M | $56.47M | N/A / N/A | = | -14.6% | Details |
| 2/29/12 |
|
Q411 | $0.00 | -$0.09 | +$0.09 | $57M | $56.21M | N/A / N/A | = | -33.2% | Details |
| 11/3/11 |
|
Q311 | -$0.10 | -$0.10 | $0.00 | $55.9M | $53.87M | N/A / N/A | = | -39.3% | Details |
| 8/3/11 |
|
Q211 | -$0.10 | -$0.11 | +$0.01 | $53.8M | $50.91M | N/A / N/A | = | -19.8% | Details |
